Prescribing overview
Bronchodilator; feline respiratory use is extra-label.
Oral terbutaline use is documented in cats with bronchial disease.
Key prescribing checks
- Bronchodilation does not replace treatment of airway inflammation.
Uses by species
Approval and evidence apply to the named product, species, route and indication. An extra-label use requires its own prescribing assessment; a human indication is not an animal approval.
Pharmacology & pharmacokinetics
Mechanism and clinical role
Beta-2 stimulation relaxes airway smooth muscle.
Absorption, distribution, metabolism and elimination
Human product pharmacokinetics do not establish a feline regimen.
SAFETY REFERENCE · PRODUCT & SPECIES SPECIFIC
Contraindications & cautions
Contraindications identify circumstances where the source says a product should not be used. Precautions call for assessment or monitoring. Interactions identify combinations to review. They are distinct categories; this summary does not replace a full interaction check or the current product label.
Terbutaline
Reviewed product labeling; human restrictions require veterinary interpretation unless an animal label is specified.
Contraindications · when not to use
- Human label: hypersensitivity to sympathomimetic amines or product components.
Precautions & monitoring
- Cardiovascular effects, hypokalemia and hyperglycemia require caution.
Species status describes the reviewed evidence, not permission to self-prescribe.
Safety sources checked: . Selected label information; independent veterinary or veterinary-pharmacy review remains pending. A label for dogs, cats, horses or humans does not establish safety for another species.
Adverse effects
Tremor, nervousness and tachycardia; electrolyte changes and arrhythmia are possible.
These are selected source-reported effects, not incidence estimates or an exhaustive list. Spontaneous postmarketing reports do not by themselves establish frequency or causality.
Dosing & administration
A verified veterinary dose has not been entered for this product. Human-label dosing must not be used as an animal regimen. Consult a current species-specific clinical source and the prescribing veterinarian.
Veterinarian selects the individual regimen; no human doses are transferred to animals.
Extra-label prescribing and food-animal residue requirements are separate from labeled regimens. FDA extra-label-use guidance ↗
Drug & supplement interactions
This monograph summarizes selected interactions. The comparison tool applies a curated set of rules and is not comprehensive. Reconcile prescription drugs, nonprescription products, supplements and recent treatment changes.
Compare with other medications and check species →
Identified formulation
Reviewed product labeling; human restrictions require veterinary interpretation unless an animal label is specified.
- MAO inhibitors/TCAs can intensify vascular effects; beta-blockers oppose bronchodilation; loop diuretics may worsen hypokalemia.
Monitoring
Breathing, heart rate, potassium and glucose when indicated.
Client counseling
Respiratory distress requires urgent veterinary care.
This section supports the veterinary team's discharge discussion; it does not replace the product’s Client Information Sheet where one is required.
Storage & handling
Follow the dispensed container; protect from children and accidental animal ingestion.
Brands, formulations & ingredient identity
Active ingredients
Terbutaline
Human tablets and injectable preparations are distinct.
Shared ingredients do not establish interchangeable concentrations, routes, release properties, species labeling or regional availability.
This entry is indexed by its generic ingredient name; verify the actual manufacturer and package.
References & review status
Clinical reference updated October 26, 2026. Independent veterinary or veterinary-pharmacy review not yet completed. Evidence gaps remain explicitly identified; this page does not claim equivalence to a comprehensive, professionally reviewed veterinary formulary.
Search another medication or supplement →